Bafna Pharmaceuticals bulk deals, insider trading and stake changes
NSE: BAFNAPHBSE: 532989Pharmaceuticals & BiotechnologySmall Cap
Last close ₹442.95down ₹9.00 (1.99%)BSE ₹449.85
Share price at the NSE close on 23 Oct 2026. Previous close ₹451.95.
52-week range of traded prices to 23 Oct 2026
₹94.77Low, 16 Mar 2026₹479.95High, 21 Oct 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,048 Cr2,105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 134.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 10.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 8.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 4.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.39
- Volume, NSEVolume. Shares traded on the last trading day.
- 1,422
Bafna Pharmaceuticals insider trading
All 24 disclosures on record. The company's own latest disclosure on record is from Mar 2025.Insider trading, all companies
Mar 2025
- SRJR LIFESCIENCES LLP₹2.10 Cr2,92,359 sharesSold or invoked · Promoter · 28 Mar 2025 · disclosed 2 Apr
- SRJR LIFESCIENCES LLP₹2.26 Cr3,14,530 sharesGave · Promoters · 28 Mar 2025 · disclosed 29 Mar · Others · stake 75.90% before, 74.57% after
- SRJR LIFESCIENCES LLP₹20 Cr28,25,356 sharesSold or invoked · Promoter · 27 Mar 2025 · disclosed 2 Apr
- SRJR LIFESCIENCES LLP₹20 Cr28,30,766 sharesGave · Promoters · 27 Mar 2025 · disclosed 29 Mar · Others · stake 87.86% before, 75.90% after
Feb 2024
- SRJR LIFESCIENCES LLP₹0.11 Cr12,442 sharesSold or invoked · Promoter · 20 Feb 2024 · disclosed 29 Feb
Dec 2023
- SRJR LIFESCIENCES LLP₹0.39 Cr41,919 sharesSold · Promoter · 28 Dec 2023 · disclosed 29 Dec · stake 88.08% before, 87.90% after
- SRJR LIFESCIENCES LLP₹0.22 Cr23,401 sharesSold · Promoter · 26 Dec 2023 · disclosed 28 Dec · stake 88.18% before, 88.08% after
- SRJR LIFESCIENCES LLP₹0.30 Cr30,000 sharesSold · Promoter · 22 Dec 2023 · disclosed 23 Dec · stake 88.30% before, 88.18% after
Sep 2023
- SRJR LIFESCIENCES LLP₹1.41 Cr1,57,248 sharesGave · Promoter · 7 Sep 2023 · disclosed 11 Sep · Market · stake 89.57% before, 88.90% after
Sep 2022
- SRJR LIFESCIENCES LLP₹0.09 Cr8,897 sharesSold · Promoters · 14 Sep 2022 · disclosed 20 Sep · stake 89.60% before, 89.57% after
- SRJR LIFESCIENCES LLP₹0.11 Cr9,883 sharesSold · Promoters · 7 Sep 2022 · disclosed 15 Sep · stake 89.65% before, 89.60% after
- SRJR LIFESCIENCES LLP₹0.11 Cr10,000 sharesSold · Promoter · 2 Sep 2022 · stake 89.72% before, 89.68% after
Jun 2022
- SRJR LIFESCIENCES LLP₹0.09 Cr7,495 sharesSold or invoked · Promoter · 16 Jun 2022 · disclosed 23 Aug
- SRJR LIFESCIENCES LLP₹0.33 Cr27,218 sharesSold · Promoters · 8 Jun 2022 · disclosed 16 Jun · stake 89.94% before, 89.72% after
- SRJR LIFESCIENCES LLP₹0.17 Cr13,135 sharesSold · Promoters · 6 Jun 2022 · disclosed 8 Jun · stake 89.89% before, 89.84% after
- SRJR LIFESCIENCES LLP₹0.14 Cr11,123 sharesSold · Promoters · 3 Jun 2022 · disclosed 6 Jun · stake 89.94% before, 89.89% after
- SRJR LIFESCIENCES LLP₹0.18 Cr14,756 sharesSold · Promoters · 1 Jun 2022 · disclosed 3 Jun · stake 90.00% before, 89.93% after
Earlier, Sep 2020 to Apr 2021Hide earlier
Apr 2021
- AMRIBAI BAFNA50,000sharesInvoked · Promoters · 13 Apr 2021 · disclosed 2 Sep · Invocation of pledge · stake 0.22% before, 0.01% after
- SASIKALA BAFNA62,757sharesInvoked · Promoters · 13 Apr 2021 · disclosed 2 Sep · Invocation of pledge · held 62,757 before
- PARAS BAFNA41,167sharesInvoked · Promoters · 13 Apr 2021 · disclosed 2 Sep · Invocation of pledge · stake 0.39% before, 0.21% after
- MAHAVEER CHAND BAFNA1,48,507sharesInvoked · Promoters · 13 Apr 2021 · disclosed 2 Sep · Invocation of pledge · held 1,49,615 before, holds 1,108 after
- MAHAVEER CHAND BAFNA HUF15,823sharesInvoked · Promoters · 13 Apr 2021 · disclosed 2 Sep · Invocation of pledge · held 15,823 before
Feb 2021
- Chetna Bafna2,13,280sharesGave · Promoters · 25 Feb 2021 · disclosed 31 May · Gift · held 2,13,280 before
Sep 2020
- SRJR Lifesciences LLP₹55 Cr2,12,90,701 sharesReceived · Promoters · 10 Sep 2020 · disclosed 24 Dec · Preferential Offer · holds 2,12,90,701 after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Bafna Pharmaceuticals stake sales and purchases
All 5 disclosures on record.
Mar 2025
- SoldSRJR Lifesciences LLP · promoter13.30% of the company31,45,296 sharesholds 74.57% after28 Mar 2025 · filed under the 2% rule
Sep 2023
- SoldSRJR Lifesciences LLP · promoter1.26% of the company2,98,666 sharesholds 88.30% after8 Sep 2023 · filed under the 2% rule
Sep 2020
- AcquiredSRJR Lifesciences LLP · promoter90.00% of the company2,12,90,701 sharesholds 90.00% after10 Sep 2020 · filed under the 5% rule · Preferential Allotment
Feb 2012
- AcquiredBafna Mahaveer Chand · promoter0.54% of the company1,00,000 sharesholds 13.38% after23 Feb 2012 · filed under the 2% rule · Market
Dec 2008
- AcquiredSHASIKALA BAFNA2.32% of the company3,70,807 sharesholds 10.44% after4 Dec 2008
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Bafna Pharmaceuticals bulk deals
Last 12 months, since 23 Oct 2025: 1 bulk deal, ₹19 Cr bought and ₹19 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 6 Aug 20262 firms · ₹19 Cr bought · ₹19 Cr soldNet nil
- BoughtCULLINAN OPPRTS FUND VCC-CULLINAN OPPORTUNITIES INCORPORATED VCC SUB FUND 1Bought 6,66,000 at ₹284.552.82% of the company₹19 Cr
- SoldM7 GLOBAL FUND PCC-AERIONSold 6,66,000 at ₹284.552.82% of the company₹19 Cr
Tuesday 18 Aug 20151 firm · ₹0 bought · ₹0.49 Cr soldNet sold ₹0.49 Cr
- SoldAMRI BAI BAFNASold 1,58,400 at ₹30.920.85% of the company₹0.49 Cr
Monday 5 Jan 20151 firm · ₹0.34 Cr bought · ₹0 soldNet bought ₹0.34 Cr
- BoughtSUBRAMANIAN SHANMUHAMBought 1,00,000 at ₹33.500.54% of the company₹0.34 Cr
Monday 21 Jul 20141 firm · ₹0.36 Cr bought · ₹0.33 Cr soldNet bought ₹0.03 Cr
- Both waysGAJANAN ENTERPRISESBought 94,380 at ₹37.85Sold 88,541 at ₹36.970.51% of the companyNet +5,839 shares₹0.36 Cr bought
Thursday 10 Apr 20142 firms · ₹0.58 Cr bought · ₹0.31 Cr soldNet bought ₹0.27 Cr
- BoughtPILOT CONSULTANTS PVT LTDBought 2,08,756 at ₹27.631.12% of the company₹0.58 Cr
- SoldS A MANIKANDANSold 1,11,000 at ₹27.860.59% of the company₹0.31 Cr
Tuesday 26 Nov 20133 firms · ₹2.36 Cr bought · ₹3.90 Cr soldNet sold ₹1.54 Cr
- Both waysSHAH NIRAJ RAJNIKANTBought 18,302 at ₹31.05Sold 4,82,302 at ₹32.352.59% of the companyNet −4,64,000 shares₹0.06 Cr bought
- Both waysYADAV PALATBought 2,12,023 at ₹31.74Sold 2,12,023 at ₹33.241.14% of the companyNet nil₹0.67 Cr bought
- Both waysMANAV N PATELBought 4,96,060 at ₹32.81Sold 4,96,060 at ₹32.912.66% of the companyNet nil₹1.63 Cr bought
Monday 5 Nov 20121 firm · ₹0 bought · ₹0.60 Cr soldNet sold ₹0.60 Cr
- SoldSAMIR HARSHAD MEHTASold 1,27,858 at ₹46.720.70% of the company₹0.60 Cr
Tuesday 16 Oct 20121 firm · ₹0 bought · ₹0.61 Cr soldNet sold ₹0.61 Cr
- SoldSABITHA KRISHNANSold 1,25,000 at ₹48.850.68% of the company₹0.61 Cr
Monday 15 Oct 20121 firm · ₹0 bought · ₹0.49 Cr soldNet sold ₹0.49 Cr
- SoldHARSHIL DIPAK SHAHSold 1,00,000 at ₹48.900.54% of the company₹0.49 Cr
Monday 8 Oct 20129 firms · ₹2.87 Cr bought · ₹2.83 Cr soldNet bought ₹0.04 Cr
- BoughtNIRAJ RAJNIKANT SHAHBought 2,20,624 at ₹47.791.20% of the company₹1.05 Cr
- SoldRAJESH KANJI SHAHSold 1,15,417 at ₹45.640.63% of the company₹0.53 Cr
- SoldHARSHIL DIPAK SHAHSold 1,00,000 at ₹47.970.54% of the company₹0.48 Cr
- BoughtSANJAY CHUNILAL SHAHBought 1,00,000 at ₹46.000.54% of the company₹0.46 Cr
- SoldDWARKADAS CHANDAKSold 1,00,000 at ₹45.790.54% of the company₹0.46 Cr
- SoldSABITHA KRISHNANSold 92,100 at ₹47.960.50% of the company₹0.44 Cr
- BoughtSAMIR HARSHAD MEHTABought 95,000 at ₹45.740.52% of the company₹0.43 Cr
- Both waysBHAGWANDAS MAHESH KUMARBought 1,00,000 at ₹45.79Sold 1,00,000 at ₹46.000.54% of the companyNet nil₹0.46 Cr bought
- Both waysSWATI DWARKA MAHESHWARIBought 1,00,000 at ₹46.00Sold 1,00,000 at ₹46.000.54% of the companyNet nil₹0.46 Cr bought
Friday 28 Sep 20122 firms · ₹0.96 Cr bought · ₹0.68 Cr soldNet bought ₹0.28 Cr
- BoughtNIRAJ RAJNIKANT SHAHBought 2,14,622 at ₹44.561.17% of the company₹0.96 Cr
- SoldMEHUL MADHUSUDAN SHAHSold 1,50,000 at ₹45.000.82% of the company₹0.68 Cr
Thursday 16 Aug 20122 firms · ₹0.68 Cr bought · ₹0.68 Cr soldNet nil
- BoughtLINDAJEET KAUR RUPRAIBought 1,50,000 at ₹45.500.82% of the company₹0.68 Cr
- SoldVISTAR FINANCIERS PVT LTDSold 1,50,000 at ₹45.500.82% of the company₹0.68 Cr
Thursday 14 Jun 20121 firm · ₹0 bought · ₹0.50 Cr soldNet sold ₹0.50 Cr
- SoldMAHAVEER CHAND BAFNASold 1,05,060 at ₹47.500.57% of the company₹0.50 Cr
Monday 4 Jun 20122 firms · ₹0.49 Cr bought · ₹0.49 Cr soldNet nil
- SoldGAURAV RAJNI PARIKHSold 1,00,000 at ₹49.340.54% of the company₹0.49 Cr
- BoughtMAHAVEER CHAND BAFNABought 1,00,000 at ₹49.340.54% of the company₹0.49 Cr
Friday 9 Mar 20122 firms · ₹0.51 Cr bought · ₹0.49 Cr soldNet bought ₹0.02 Cr
- BoughtLINDAJEET KAUR RUPRAIBought 1,03,250 at ₹49.00₹0.51 Cr
- SoldVISTAR FINANCIERS PVT LTDSold 1,00,000 at ₹48.99₹0.49 Cr
Thursday 23 Feb 20122 firms · ₹0.47 Cr bought · ₹0.66 Cr soldNet sold ₹0.19 Cr
- SoldNIRAJ RAJNIKANT SHAHSold 1,41,400 at ₹46.42₹0.66 Cr
- BoughtMAHAVEER CHAND BAFNABought 1,00,000 at ₹46.69₹0.47 Cr
Thursday 16 Feb 20123 firms · ₹1.06 Cr bought · ₹1.01 Cr soldNet bought ₹0.04 Cr
- SoldNIRAJ RAJNIKANT SHAHSold 1,01,000 at ₹46.55₹0.47 Cr
- BoughtGAURAV RAJNI PARIKHBought 99,559 at ₹47.09₹0.47 Cr
- Both waysBHAGWANDAS MAHESH KUMARBought 1,25,025 at ₹46.93Sold 1,15,062 at ₹47.10Net +9,963 shares₹0.59 Cr bought
Monday 5 Sep 20112 firms · ₹0.48 Cr bought · ₹0.48 Cr soldNet nil
- BoughtLINDAJEET KAUR RUPRAIBought 1,00,000 at ₹48.45₹0.48 Cr
- SoldVISTAR FINANCIERS PVT LTDSold 1,00,000 at ₹48.45₹0.48 Cr
Thursday 31 Mar 20111 firm · ₹0 bought · ₹0.32 Cr soldNet sold ₹0.32 Cr
- SoldASSOCIATED CAPSULES PRIVATE LIMITEDSold 80,000 at ₹39.53₹0.32 Cr
Thursday 10 Mar 20111 firm · ₹0.46 Cr bought · ₹0 soldNet bought ₹0.46 Cr
- BoughtNIRAJ RAJNIKANT SHAHBought 1,00,000 at ₹46.00₹0.46 Cr
Wednesday 8 Dec 20101 firm · ₹0.45 Cr bought · ₹0 soldNet bought ₹0.45 Cr
- BoughtNIRAJ RAJNIKANT SHAHBought 1,00,000 at ₹45.00₹0.45 Cr
Friday 12 Nov 20106 firms · ₹3.39 Cr bought · ₹3.55 Cr soldNet sold ₹0.16 Cr
- SoldLAKSHIMINARAYANA SSold 1,24,000 at ₹50.77₹0.63 Cr
- BoughtRAGHUNATHA REDDY MEDABought 88,503 at ₹51.83₹0.46 Cr
- Both waysBAKSHU SECURITIES AND BROKER PRIVATE LIMITEDBought 2,12,566 at ₹53.02Sold 2,12,566 at ₹52.60Net nil₹1.13 Cr bought
- Both waysATMAN HARSHAD SANGHAVIBought 1,47,086 at ₹50.51Sold 1,47,086 at ₹50.34Net nil₹0.74 Cr bought
- Both waysPREMSHANKER A MEHTABought 1,02,697 at ₹53.83Sold 1,02,697 at ₹53.73Net nil₹0.55 Cr bought
- Both waysJ V STOCK BROKING PRIVATE LIMITEDBought 97,695 at ₹51.83Sold 97,695 at ₹51.85Net nil₹0.51 Cr bought
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. The latest 51 deals, on record since listing on 27 Jun 2008.